Edoxaban for TIA and Acute Minor Stroke

Clinical trial NCT02221102 · UNKNOWN

Trial details

NCT number: NCT02221102
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischemia Stroke Cerebral Infarction

Start date: 2013-12-01
Primary completion: 2015-06-01
Enrollment: 3700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.